Stevanato Group (NYSE:STVN) Shares Up 0.3% – Time to Buy?

by · The Markets Daily

Stevanato Group S.p.A. (NYSE:STVN – Get Free Report)’s stock price was up 0.3% during trading on Wednesday . The company traded as high as €23.95 ($24.95) and last traded at €23.75 ($24.74). Approximately 175,372 shares were traded during trading, a decline of 65% from the average daily volume of 499,712 shares. The stock had previously closed at €23.67 ($24.66).

Wall Street Analyst Weigh In

A number of research firms have issued reports on STVN. Bank of America boosted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, Wolfe Research started coverage on Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of €28.60 ($29.79).

Get Our Latest Stock Analysis on Stevanato Group

Stevanato Group Price Performance

The business’s 50 day moving average is €20.01 and its 200-day moving average is €19.76. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $6.14 billion, a P/E ratio of 44.17, a PEG ratio of 10.49 and a beta of 0.59.

Stevanato Group (NYSE:STVN – Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. During the same quarter in the previous year, the business posted $0.16 EPS. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in STVN. nVerses Capital LLC bought a new stake in shares of Stevanato Group during the third quarter worth $84,000. Raymond James Trust N.A. grew its position in Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after acquiring an additional 1,613 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in Stevanato Group by 59.2% in the second quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock valued at $219,000 after purchasing an additional 4,441 shares during the last quarter. Hardy Reed LLC boosted its position in Stevanato Group by 8.2% during the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after buying an additional 840 shares during the period. Finally, Lindenwold Advisors INC increased its position in Stevanato Group by 13.5% in the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after acquiring an additional 1,415 shares during the period.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles